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REVIEW ARTICLE OPEN
Digital health interventions in palliative care: a systematic
meta-review
Anne M. Finucane1,2✉, Hannah O’Donnell3, Jean Lugton2, Tilly Gibson-Watt 4, Connie Swenson2 and Claudia Pagliari 3
Digital health interventions (DHIs) have the potential to improve the accessibility and effectiveness of palliative care but heterogeneity
amongst existing systematic reviews presents a challenge for evidence synthesis. This meta-review applied a structured search of ten
databases from 2006 to 2020, revealing 21 relevant systematic reviews, encompassing 332 publications. Interventions delivered via
videoconferencing (17%), electronic healthcare records (16%) and phone (13%) were most frequently described in studies within
reviews. DHIs were typically used in palliative care for education (20%), symptom management (15%), decision-making (13%),
information provision or management (13%) and communication (9%). Across all reviews, mostly positive impacts were reported on
education, information sharing, decision-making, communication and costs. Impacts on quality of life and physical and psychological
symptoms were inconclusive. Applying AMSTAR 2 criteria, most reviews were judged as low quality as they lacked a protocol or did
not consider risk of bias, so findings need to be interpreted with caution.
npj Digital Medicine            (2021) 4:64 ; https://doi.org/10.1038/s41746-021-00430-7
INTRODUCTION
The diagnosis of a life-limiting illness, along with its management
during periods of wellness, illness, remission, decline and end of
life can be stressful for patients, caregivers and healthcare
professionals. Palliative care offers a holistic set of approaches
for ameliorating the physical, psychological, social and spiritual
burdens that patients and their families can face when dealing
with the challenges associated with advanced progressive
incurable illness, end of life and bereavement1,2. It prevents and
relieves suffering through early identification, assessment and
symptom management; including addressing practical needs and
providing bereavement support. Digital health interventions
(DHIs) in palliative care need to address the holistic needs and
preferences of people with deteriorating health; and maintain
patient–professional relationships that are dignity-enhancing and
focused on patient and caregiver values and goals3. Improving
access to, and increasing the quality of palliative care delivered is a
healthcare priority in many countries4,5. DHIs could have an
essential role to play in achieving these aims.
Digital health, or eHealth, is a broad term used to refer to the
application of information and communication technologies (ICTs)
and networks for the management, delivery and optimisation of
patient care and health services, and for supporting patients
themselves. It encompasses a range of related concepts such as
telemedicine and telehealth, mobile health (mHealth), health
informatics and wearable devices6,7. The adoption of digital health
technologies is rapidly changing how healthcare is provided.
Electronic health records (EHRs) and decision support tools are
part of routine healthcare practice in many countries, while the
use of videoconferencing to provide care at a distance is
becoming more common. Mobile phones, apps, wearables and
social media are in widespread use by citizens/patients, and
innovations such as augmented reality, virtual assistants and
artificial intelligence (AI) are finding new uses in clinical manage-
ment and patient self-care. These approaches are reshaping
healthcare as they become more affordable and widespread3.
Palliative care is one area where these technologies are
increasingly being deployed8. Research to establish the feasibility
of using videoconferencing in palliative care was first reported 20
years ago9. In healthcare organisations, pathways and preferences
for palliative care are being steadily integrated into EHRs10. In
parallel, mobile applications and online social networks for
supporting patients’ physical, cognitive and emotional needs are
becoming popular, both supplied by healthcare providers11 and
driven by patients and caregivers themselves12. More recently,
predictive analytics and AI are being used to adapt clinical
interventions to stages of terminal illness13.
Reflecting this activity, there has been a significant rise in the
number of systematic reviews focused on DHIs and palliative care
over the past 15 years14–18. Despite their general support for these
approaches, the clinical scope and quality of existing reviews varies
widely, making it difficult to evaluate their implications for the field
as a whole. Given the growing demand for palliative care services
worldwide19 and the increasing penetration of DHIs in healthcare,
the time is right for a comprehensive synthesis and appraisal of this
evidence base. We employed the meta-review method to capture,
appraise and synthesise the evidence represented in the systematic
review literature on DHIs in palliative care. Our objectives were:
(1) To identify the DHIs used in context of palliative care
described in existing systematic reviews.
(2) To describe the overall quality of existing systematic
reviews.




The database searches returned a total of 5092 titles and abstracts,
of which 55 potentially relevant papers were subjected to full-text
review and 21 were eligible for inclusion (Fig. 1). The main reason
1Clinical Psychology, School of Health in Social Science, University of Edinburgh, Edinburgh, Scotland, UK. 2Marie Curie Hospice Edinburgh, Edinburgh, Scotland, UK. 3The Usher
Institute, University of Edinburgh, Edinburgh, Scotland, UK. 4Edinburgh Medical School, University of Edinburgh, Edinburgh, Scotland, UK. ✉email: a.finucane@ed.ac.uk
www.nature.com/npjdigitalmed













for excluding articles at full-text review was that they were not
focused on palliative care (13 studies) or DHIs (7 studies); not
systematic reviews (4 studies); did not search databases of
published literature (3 studies); did not report on effects of DHIs
or provide detail on included reviews (4 studies) or other reasons
(3 studies). During the search process, we identified one meta-
review of telemedicine in palliative care published in 201620. This
meta-review identified a total of 6 systematic reviews published
between 2007 and 2012, all of which were included amongst the
21 eligible reviews in this meta-review.
Description of the included systematic reviews
Characteristics of the 21 included reviews are shown in Supple-
mentary Table 1. Most included a range of study populations—
patients, family members, caregivers and health professionals. Two
reviews solely considered evidence on interventions for care-
givers18,21, two were concerned with perspectives of healthcare
professionals22,23, while one was applied specifically to paediatric
palliative care14. Two reviews focused on cancer24,25, others did not
limit their inclusion criteria to a specific disease. The reviews were
carried out by research teams based on the following countries:
Fig. 1 Prisma flow diagram. Overview of the search process.
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USA (n= 9)17,18,21,22,26–30, UK (n= 6)10,16,25,31–33, Australia (n=
2)14,34, Canada (n= 1)24, Chile (n= 1)15, Denmark (n= 1)35 and
Brazil (n= 1)23.
The 21 reviews were published between 2007 and 2019 and
included primary research papers spanning 1997–2018. Ten systema-
tic reviews covered broad areas such as telehealth14,16,18,21,30,33,
telehospice17, ehealth15 and ICTs25,26. Eleven reviews had a more
specific focus: EHRs10,28,29,34, internet23,27, weblogs31, mhealth32,
telephone24, videoconferencing35 and simulators22.
The number of studies related to DHIs and palliative care in
each review ranged from 532 to 3935. Taken together the reviews
summarised evidence from 332 unique publications, including
four systematic reviews and one PhD thesis. Drawing on the
Physician Data Query (PDQ) Levels of Evidence, used by the
National Cancer Institute36 to appraise Supportive and Palliative
Care studies, we categorised publications within the 21 systematic
reviews into one of four levels. Level 1 represented study designs
typically considered to offer the strongest evidence and Level 4
the weakest. Only 12% of publications were Level 1. Of the 43
publications describing randomised controlled trials (RCTs), 29
were unspecified trials, 13 were pilot or feasibility trials and one
was a Phase II trial. Four of these were classed as Level 2 due to
their scale or scope. Most publications described retrospective and
qualitative designs (Level 3) (Fig. 2).
Most primary publications within the systematic reviews were
included in only one review (70%, n= 279); one-fifth appeared in
two publications (21%, n= 84), 7.5% appeared in three reviews
(n= 30) and only 1.3% appeared in five reviews (n= 5). For further
detail on the individual publications within each systematic
review, see Supplementary Tables 1, 2 and Supplementary Data 1.
Range of DHIs for palliative care described in existing
systematic reviews and individual publications within the
reviews
We classified the types of DHIs described in the 328 studies
represented within the 21 reviews (Table 1). The most common
types of DHIs involved videoconferencing or videophone (n= 56,
17%), EHRs (n= 51, 16%) and telephone or mobile phone (n= 41,
13%). Online interventions, including educational websites and
online courses, were described in 31 publications (9%). Only six
publications were focused on social media (2%), e.g. interactive
online blogs. We found a relatively large proportion of publications
describing mixed or unspecified DHIs (n= 50, 15%). Some DHIs
were delivered using a mix of technologies or contained multiple
components (e.g. telephone call with follow-up video-consultation).
DHIs were used for a range of purposes in palliative care
(Table 2). A fifth of publications described DHIs for educational
purposes (n= 64) most frequently involving online learning,
simulators and videoconferencing targeting professionals. Symp-
tom management was the main aim of DHIs outlined in 15% of
publications (n= 49), and all types of DHI were used for this
purpose. Information provision or management, often using EHRs,
was the main aim of DHIs in 13% of publications (n= 44).
Communication was the main aim of DHIs in 9% of publications
(n= 29), with videoconferencing most often used. Decision-making
support for patients and professionals was the main purpose of
DHIs described in 13% of publications (n= 42)—video aids and
EHRs were often used for this purpose. Overall, 15% of publications
(n= 49) described DHIs for mixed or unspecified purposes. Mixed
purposes could include information support and decision-making
or communication and information sharing. Unspecified purposes
had no specific focus.
Quality of evidence
Applying the AMSTAR 2 critical appraisal tool for systematic
reviews, only one review was judged as moderate quality35. At
least one of the AMSTAR 2 ‘critical domains’ was missing from all
Fig. 2 Publications categorised by PDQ Levels of Evidence. Excludes four systematic reviews and one PhD thesis.
Table 1. Types of DHIs reported in publications included in
21 systematic reviews.








Electronic health records 51 16%





High-fidelity simulator 16 5%
Other (e.g. digital pens) 7 2%
Social media 6 2%
Telemonitoring 5 2%
Text messaging 2 1%
Mixed/unspecified 50 15%
Total 328 100%
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other reviews (n= 20) (Supplementary Table 3), and overall quality
of all other reviews was rated low (n= 15) or very low (n= 5)
because of this. Only three systematic reviews referred to a study
protocol or specific guide developed prior to the conduct of the
review22,33,35. Most (n= 13) did not consider risk of bias. All were
judged to have partially conducted a comprehensive literature
review, though none had searched all sources identified in the
AMSTAR 2 constituting a fully comprehensive search. Most
reviews provided a satisfactory explanation for the heterogeneity
of findings in their discussion (n= 17). Of the non-critical domains,
none of the reviews explicitly defined all components of PICO
when describing the research question, few provided a list of
excluded studies (n= 3) and only one-third used a satisfactory
technique for analysing risk of bias in individual studies. Most
conducted study selection and data extraction in duplicate,
reported sources of funding and potential conflicts of interest.
Meta-analysis was not conducted in any review due to the
heterogeneity of included study designs and outcomes.
Eleven systematic reviews assessed the quality of evidence of
included publications10,14,17,18,21,22,26,30,33–35. Four used the
Cochrane risk of bias tool18,26,30,34. One used the Critical Appraisal
Skills programme tool14. Five reviews used different tools
previously described in the literature10,21,22,33,35 while one
developed a quality appraisal framework specifically for their
review17. Three reviews described evidence as moderate-to-high
quality14,17,21. Eight reviews reported evidence of low-to-moderate
quality10,18,22,26,30,33–35. This was due to small sample size,
insufficient detail on study design, unclear or high risk of bias,
non-blinding of participants and outcomes, and poorly defined
comparison groups.
Role and effects of DHIs for palliative care
Findings from each review are described in relation to seven
thematic areas: education, symptom management, information
sharing, decision-making, communication, quality of life (QoL) and
cost-effectiveness.
Education
Eight reviews identified DHIs for education, of which most focused
on describing interventions rather than evaluating their
outcomes15,16,21–23,26,32,33. Educational interventions were deliv-
ered via online learning for professionals15,18,23,26, videoconferen-
cing for professionals16,33,37, videos for professionals19,26,29, online
symptom reporting for caregivers21, simulation-based learning
experiences for professionals22 and mobile phones/text messaging
for education and training of providers and patients32. Two reviews
reported that online learning was a feasible alternative to in-person
training, though quality of evidence of primary studies within these
reviews was not assessed16,23. In a review of distance learning for
healthcare professionals, Taroco et al. suggested that online case
consultations involving active participation of students facilitated
knowledge retention23. They also noted the prevalence of mixed
educational initiatives (i.e., distance learning and classroom-based),
with 64% of studies involving mixed approaches, suggesting a
need for classroom activity to consolidate knowledge acquired at a
distance. There was no consensus about the most-effective
learning methods, and most virtual learning environments used
a variety of multimedia to support communication and feedback
mechanisms. Kidd et al.16 suggested that online learning and
remote access to guidelines supports dissemination of good
practice but also reported that face-to-face teaching methods are
preferred when discussing emotional or psychological issues.
Ostherr et al.26 reported strong evidence for benefits of video for
educating patients about their illness and helping to determine
treatment choices. Smith et al. sought to examine evidence on the
use of simulation-based learning for end-of-life care conversations
in their review, but found that information on outcomes was
absent22. Overall, evidence on the impact of DHIs on education
was mainly positive, though studies were mostly descriptive,
outcomes assessed were heterogeneous, and evidence quality was
not generally examined.
Symptom management
Thirteen reviews referenced the role of DHIs in monitoring,
assessing and managing physical and psychological symp-
toms14–18,21,24–26,28,30,33,35. EHRs were used to record symptoms28,33
while telephone and videoconferencing were frequently used to
monitor, assess and treat symptoms15,18,24–26,31,35. Some reviews
described positive impacts of DHIs on symptom management,
while most reviews identified inconsistent evidence or noted that
evaluation of impact in many studies was lacking. Describing
evidence with moderate certainty, Jess et al.35 identified positive
impacts of videoconferencing on symptom burden, especially in
remote settings, though also noted negative impacts in some
studies, specifically due to technical challenges, which caused
communication problems. Zhou et al.24 concluded that telephone
follow-up, for patients with advanced cancer, is a feasible
alternative to hospital follow-up for symptom palliation and
reduces travel burden. Head et al.30 reported positive or no
impacts of DHIs on patient symptoms (e.g. physical and social
functioning), noting that overall evidence from primary studies
within their review was weak. Hancock et al.33 described home
telemonitoring initiatives for patients (e.g. use of the telephone or
computer software to record clinical symptoms at home); however,
most interventions had not been evaluated. The heterogeneity of
outcomes used to assess particular symptoms such as pain was
highlighted by Allsop et al.25. Bush et al.28 described evidence
linking the documentation of clinical symptoms on an EHR to
reduced time in hospital in the last 6 months of life, though this
finding was based on just one publication included in their review,
and was not directly evaluated in others.
Seven reviews reported mostly positive effects of DHIs on
psychological symptoms—anxiety, depression and dis-
tress14,17,18,21,30,31,35. Jess et al.35 identified largely positive impacts
of videoconferencing on patient and caregiver anxiety, with the
exception of one RCT, which found negative impacts38. This RCT
compared weekly video-consultations by a palliative care
Table 2. Main purpose of DHIs reported in publications included in 21
reviews.
Purpose of Digital Health
Intervention
No. of publications % of publications
Education 64 20%




Decision-making support 42 13%
Communication 29 9%




Out of hours care/emergency
admissions
9 3%
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specialist with treatment as usual in home-dwelling patients with
advanced cancer. The RCT authors concluded that higher distress
in the video-consultation arm may have been due to excess focus
on symptoms and suffering, and the provision of pre-scheduled
support over 3 months as opposed to when it was actually
needed38. Bradford et al.14 described a number of small studies
examining videoconferencing interventions for paediatric pallia-
tive care, noting reductions in anxiety. Head et al.30 identified
positive effects of DHIs (telemonitoring and videoconferencing)
on patient anxiety, depression and distress. Zheng et al.18
reported significant improvements in caregiver anxiety associated
with access to videophones. Parker-Oliver et al.17 identified studies
examining the effect of DHIs on anxiety, though studies were not
large enough to detect significant differences in outcomes.
Ngwenya et al.31 focusing on online blogging, reported that
patients experienced a sense of emotional support, social
connections and empowerment through writing online blogs.
Information sharing
Eight reviews considered the information-sharing value of DHIs,
with most describing the value of the information rather than
evaluating specific outcomes10,15,16,25,27–29,34. In an early review of
internet use, Willis et al. described the positive impacts of the
internet as an additional source of information for patients,
families and clinicians27. They found that patients and caregivers
used online support groups and chatrooms to exchange informa-
tion about an illness and alternative treatments. Patients and
caregivers developed a connection with others online and
appreciated the anonymity associated with online support.
Capurro et al.15 reported that DHIs were used by clinicians,
patients and caregivers to meet informational needs regarding
pain and symptom management and medication use. Kidd et al.
highlighted the importance of telephone helplines for general
practitioners, nurses and caregivers for gathering information
about managing symptoms and medical equipment16. These
telehealth interventions improved the reliability and accuracy of
information exchanged16. Allsop et al.25 noted that many systems
designed to capture information from a patient for use by a
healthcare professional, involved relaying symptoms without
engaging in active forms of communication.
Four reviews highlighted the information-sharing function of
EHRs in palliative care10,28,29,34. These reviews concluded that EHRs
available across settings and platforms allow patient preferences
regarding advance care planning (ACP) to be shared, improving
continuity of care and ensuring that patients are treated in line
with their wishes. Bush et al.28 reported that in low-resource
settings, the implementation of a standalone EHR system
capturing patient demographics and palliative care treatment
information was found to significantly improve clinical workflow.
Leniz et al.10 found that those with an EHR shared across settings
were more likely to die in their preferred place compared with
those who did not have an EHR. However, EHRs were limited in
their capacity to capture important qualitative information such as
information on anxiety or family distress28. Furthermore, locating
relevant ACP information within the EHR was often challenging34,
though could be improved by ensuring all ACP information is
documented in a specific area28. Documentation templates, order
sets and prompts may also improve the quality and incidence of
ACP within EHRs29. Having an EHR improves documentation of
advance care plans and communication of care planning
information28,29,34, but this can come at the cost of increased
workload10, challenges identifying which patients should have a
shared EHR34, and concerns regarding data-sharing, security and
consent10. Huber et al.29 suggest that further research focused on
developing a consensus definition for ACP documentation and
related quality elements in EHRs is needed.
Decision-making
Four reviews considered the role of DHIs in decision-making by
patients26 and professionals23,28,34. Ostherr et al. identified
20 studies where video, computer-based multimedia and online
materials were used to support communication between patients,
families and staff in context of end-of-life decision-making26.
There was evidence for the efficacy of video in facilitating ACP
decisions, resulting in improvements in completion of advance
directives, discussion of end-of-life preferences and improved
patient knowledge and satisfaction. Taroco et al. identified two
studies on distance-learning courses for decision-making in
palliative care, but did not describe the outcomes23. Two reviews
considered the role of clinical decision support systems (CDS),
including EHRs in facilitating decision-making28,34. Bush et al.28
described evidence on the use of such systems to identify patients
for a palliative care approach, and to capture ACP directives and
patient-reported outcomes to inform clinical decision-making.
Due to heterogeneity of studies, evidence could not be
synthesized. However, Bush et al.28 described positive impacts
including a reduced likelihood of ICU admissions and hospital
death for those with patient-reported outcomes shared via EHR,
compared to those without; and earlier identification of patients
for ACP discussion. Lemon et al.34 found that EHRs can improve
documentation of advance directives. Electronic reminders,
electronic templates, decision aids and standard locations of
advance directives increase documentation. Electronic search
systems and identification algorithms located within the EHR
can assist with identification of patients who could potentially
benefit from a palliative care approach, by flagging those who
may have palliative care needs for review by the clinician. Overall,
the evidence from publications included in Lemon et al. was weak,
but points towards promising potential effects of EHRs for ACP.
Communication
Ten reviews described the role of DHIs to facilitate communication
between patients, professionals and caregivers using phones,
internet and computer systems15,21,22,25–27,30–32,35. Positive effects
included enhanced communication between patients, healthcare
professionals and caregivers;15,21,27,35, more opportunities to
express feelings31, increased connectednesss15, caregiver sup-
port17 and improved ACP26. Jess et al.35 identified 16 studies
relating to the impact of videoconferencing on communication in
palliative care. Positive impacts included greater efficiency and
access, whereby several participants could be visually present and
participate at once; shared decision-making involving the multi-
disciplinary team, patient and family; and enhanced communica-
tion through access to non-verbal as well as verbal responses.
Negative impacts could occur where the family felt overwhelmed
by the involvement of too many participants. Smith et al.22 found
that simulation-based learning was frequently used to teach
nursing students communication skills in palliative care settings,
but due to the lack of standardization and poor evaluation, it was
difficult to identify best practices.
Quality of life (QoL)
Seven reviews considered the effects of DHIs on
QoL14,17,18,21,24,30,35. Most reviews described improvements that
were not statistically significant or positive impacts. Negative
impacts were rarely observed. In their review of videoconferen-
cing, Jess et al. identified several studies incorporating a QoL
measure in their design, but QoL outcomes were not described in
their findings35. Zheng et al. found no significant difference in QoL
outcomes after telehealth interventions for caregivers18. Head
et al. identified one study reporting a positive impact of telephone
monitoring on QoL whereas another involving videophones
showed no difference30. Similarly, in their review of telehealth
A.M. Finucane et al.
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for paediatric palliative care, Bradford et al.14 found either positive
effects on QoL or no significant differences. Zhou et al. reported
that telephone follow-ups with patients with advanced cancer
reduced the patient burden by eliminating the need to come into
hospital, facilitating a better QoL, though quality of evidence was
not assessed and insufficient data on included studies was
provided24. In a review of telehealth and hospice care, Oliver
et al.17 reported that studies examining QoL were too small to
identify clinically significant differences. In a review of weblogs in
palliative care, Ngwenya and Mills31 concluded that weblogs
improve patient and QoL by empowering patients and giving
them a sense of active participation in their treatment, but this
was a small scale study with no quality assessment of included
studies. In reviews of EHRs, outcomes relating to QoL were rarely
assessed10,33.
Costs and resource use
Five reviews considered the financial implications of DHIs, with
most reporting positive impacts of DHIs on costs for patients,
caregivers or providers14–17,35. Jess et al. described cost savings
associated with video consultation in palliative care for clinicians,
service providers, patients and caregivers35. In two studies within
their review, video consultations between healthcare professionals
and patients resulted in cost savings for the hospital, compared to
in-person consultations, and in clinician travel expenses for home
visits. Travel cost savings were also noted for patients and carers in
rural settings35. In a review of DHIs in hospices, Oliver et al.17
identified one telehospice cost analysis study; this study reported
reduced costs for telehospice visits versus traditional hospice
homecare. Bradford et al.14 described cost efficiencies when video
visits were used in place of home visits; and when videoconferen-
cing was used to educate patients about self-care, but cautioned
that the cost-effectiveness will depend on whether DHIs are used
in parallel with, or as a replacement for, traditional approaches.
Kidd et al. described DHIs as an efficient alternative for patients
and clinicians when time and distance is limiting16. Capurro et al.
described cost efficiencies related to reduced hospital visits, but
this was based on only one study in their review15. Overall,
evidence on costs and resource use was positive, though
interventions and outcomes assessed were heterogeneous,
findings were based on a small number of primary studies within
a small number of reviews, evidence quality was not generally
assessed and robust economic evaluation not undertaken.
DISCUSSION
Main findings
This meta-review indicates that DHIs in palliative care are being
used for education, symptom management, information sharing,
decision-making and communication, with the aim of improving
patients’ QoL and the reach and efficiency of services. Positive
impacts of DHIs were reported on education, information sharing,
decision-making and communication in palliative care contexts.
Evidence pertaining to physical and psychological symptoms and
QoL was inconclusive or absent. No evidence of risks to patient
safety was reported. However, the methodological quality of
existing systematic reviews on DHIs for palliative care was low
when judged using the AMSTAR 2 appraisal criteria, mainly due to
the absence of review protocols and risk of bias assessment. DHIs
can play a positive, enabling role in palliative care but there is a
need for more rigorous evaluation, implementation and cost-
effectiveness studies, with a greater focus on patient perspectives
and consideration of bias in study designs. Rigorous quality
guidelines should be adopted before embarking on future
systematic reviews of primary research in palliative care to
increase the confidence that can be placed in their findings.
Advantages of this study
To date this is the most comprehensive meta-review focused on
DHIs in palliative care. Compared to a previous meta-review,
which encompassed six reviews20, it examined a wider range of
databases and identified 21 systematic reviews for critical
appraisal and synthesis. This meta-review shows that DHIs are
more prevalent in palliative care than previously described, are
used for a broader range of purposes, that impacts are
generallyoften positive; and that the overall quality of research
evidence is improving. As a by-product of our review, we
provide a database of all 332 publications categorised by DHI
type and main use, which may be of use to other researchers
interested in evidence on specific DHIs for palliative care
(Supplementary Data 1).
Limitations of this study
The heterogeneity of review aims, methods and presentation of
results created challenges for evidence synthesis. In many reviews,
DHIs were described but outcomes were not evaluated in any
detail. Although the searches were completed in January 2020, the
dates of the primary studies ranged from 1997 to 2018, reflecting
the time lag in academic publishing. None of the eligible
systematic reviews focused on smartphone applications for
palliative care, despite their growing use in this context39,40.
Three reviews emerged after our searches had been completed,
including a rapid review on video consultations in palliative care in
context of COVID-1941, a scoping review of patient experiences of
telehealth for palliative care at home42 and an integrative review
of patient experiences of ehealth in palliative care43. Two would
not have been eligible, as they were not systematic reviews.
However, we suggest that future meta-reviews include all review
types. Only 3 of the 21 systematic reviews had pre-registered a
protocol on PROSPERO, which, in part accounts for the low-quality
judgements obtained when using the AMSTAR 2 appraisal criteria.
While it is true that the reviews were not as rigorous or
comprehensive as might be ideal, the weighting of this criterion
could potentially be disputed. The AMSTAR 2 appeared to be
overly stringent when used to appraise reviews in palliative care,
which tend to include heterogenous designs and outcomes often
found when evaluating complex interventions. We also acknowl-
edge that this meta-review was not pre-registered on PROSPERO,
owing to its origins in a student project. Although we use PDQ
Levels of Evidence36 to categorise studies based on their design,
we are aware that such frameworks value empirical over
normative paradigms and may underestimate the contributions
of qualitative research designs.
Methodological gaps
Systematic review registration is not commonplace in palliative
care but is needed to reduce potential for bias by reducing the
opportunity for conscious or unconscious selection or manipula-
tion of data to shape a review so that it reaches a desired
conclusion. Both systematic reviews and primary studies within
reviews need to consider sources of bias in palliative care research
and describe how this is accounted for. The components of PICO
should also be explicit, and comparison groups made clear in
future reviews.
Our meta-review findings echo the wider literature on digital
health44 and palliative care45, which point to the need for more
rigorous evaluations, cost-effectiveness analyses, implementation
studies and patient-centred research. The lack of rigorous cost-
effectiveness studies seen in the literature on DHI in palliative care
reflects findings from previous meta-reviews46,47 and systematic
reviews48–50 in digital health. There is a need for greater clarity on
what is being compared in cost-effectiveness studies, and whether
the DHI is offered in addition to, or as a replacement for, the
A.M. Finucane et al.
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standard approach14,26,35. Undertaking large, well-powered RCTs
on DHIs is challenging, partly because technological develop-
ments may outpace the timescale for conventional clinical trials51,
and also because, in practice, DHIs are implemented in complex
systems as opposed to controlled settings52. Complexity informed
paradigms that take account of dynamic interactions occurring in
the setting in which the DHI is being evaluated are needed, and
methods that pay greater attention to the factors that facilitate or
hinder adoption, such as in-depth case studies, may be more
realistic and fruitful in future evaluations of DHIs for palliative
care51,53. Evidence appraisal tools that value such methods are
also required. Interdisciplinary evaluation, combining economic,
social and clinical research, has the potential to better understand
the role of different settings, healthcare needs and patient
preferences for ensuring the appropriate, safe, acceptable and
sustainable use of DHIs in palliative care. Early user involvement
(patients, caregivers and staff) will also be a key in the design,
evaluation and implementation of DHIs in this setting54.
Technology evidence gaps
Personal health monitoring devices, such as wrist-worn activity
trackers and smartwatches are now widely used and have been
evaluated in other digital health contexts55. The absence of
evidence about the use of these may reflect the fact that most
studies of trackers are taking place in the context of chronic
disease management. Nevertheless, it suggests a need for further
research in palliative care, particularly for patients managing at
home, for whom wearables and ambient computing (e.g. smart
homes) are likely to be increasingly useful. The included
systematic reviews did not include studies on the use of
smartphone apps. Descriptive reviews on the potential that such
apps may have in palliative care are emerging and further
research is warranted39,40. Studies using machine learning and AI
for risk detection and prediction, or for delivering personalised
support based on the data from individual patients, were also not
represented amongst the included reviews, despite progress in AI-
enabled healthcare delivery56. Research exploring the use of
machine learning using EHRs to predict mortality, and identify
patients who would benefit from palliative care shows promise;
future reviews need to consider this emerging evidence57. Studies
involving robots or chatbots were not identified despite their
potential application in palliative care58. Evidence on these types
of DHIs is needed to understand their benefits and risks.
Stakeholder evidence gaps
The WHO has developed a classification framework for DHIs,
which provides a shared vocabulary for all stakeholders, including
researchers, when evaluating effectiveness and identifying gaps in
the implementation of DHIs across healthcare settings59. The WHO
organizes DHIs into overarching categories by user group: clients
(e.g. patients or caregivers), healthcare providers, health system or
resource managers and data services. Most of the research
evidence on DHIs in palliative care identified in this meta-review
was focused on DHIs for healthcare providers (e.g. healthcare
provider decision support, remote consultations; healthcare
provider communication and training) and to a lesser extent for
clients/patients (e.g. client-to-client communication via online
peer group support). No research on interventions for health
system managers or administrators in palliative care was found.
Using the WHO framework to situate research on DHIs in palliative
care, and identify gaps, facilitates engagement with the wider
health and social care sector, and highlights the type of DHIs that
may need to be prioritised for development and evaluation.
Telemedicine and related evidence gaps
Most of the evidence identified in this meta-review focused on
telemedicine, specifically remote consultations via phone and
video. This evidence is timely as the Covid-19 pandemic has
pivoted attention towards these approaches60. Remote consulta-
tions are feasible in palliative care and generally acceptable to
patients14,16,24,35 and caregivers18,35. Remote consultations are
perceived as particularly helpful when increasing access to care for
families who are otherwise isolated by geography or house-
bound14, reflecting the context for many patients and families due
to social distancing requirements during the Covid-19 pandemic.
This should help reassure healthcare professionals that patients
and caregivers often welcome these approaches, especially when
face-to-face options are limited. While guidance regarding under-
taking a remote consultation in palliative care is emerging61,
evidence gaps remain. There is a need for research to determine
when a face-to-face consultation is essential for terminally ill
patients and when remote consultation is sufficient or preferred.
Research is needed to understand contextual factors influencing
the acceptability or effectiveness of remote consultations in
palliative care47 and to shed light on inconsistent findings around
physical and psychological symptoms found in the present review
and in related research literature62. Critically, research on
equitable access to palliative care delivered using DHIs is urgently
needed to ensure that all those who need palliative care can
benefit from it.
Palliative care research participation
Research involving people who are terminally ill is difficult due to
the perceived vulnerability of the population and professional
caution37. Professional gatekeeping is a challenge63, and biased
samples consisting of patients who are mostly well or highly
motivated is often problematic. However, there is ample evidence
that many terminally ill patients are interested in taking part in
research and may benefit from doing so64,65. As patients and
caregivers grow accustomed to receiving care remotely, there will
be more opportunities to engage patients and their families in
research remotely, reducing burden and travel costs. Providing a
variety of ways in which patient and caregiver data can be
collected, including online interviews and focus groups, maximises
research participation, and is recommended.
CONCLUSIONS
DHIs are increasingly being implemented in the context of
palliative care and the Covid-19 crisis has given this further
impetus, particularly for clinical and supportive interventions at a
distance. This meta-review has synthesised the corpus of research
evidence represented by existing systematic reviews in this area.
The overall evidence suggests that DHIs can be useful, safe and
acceptable to many terminally ill patients, their caregivers and
staff involved in their care. Mostly, positive impacts were reported
on education, information sharing, decision-making, communica-
tion and costs. Impacts on QoL and physical and psychological
symptoms were inconclusive. Applying AMSTAR 2 criteria, most
reviews were judged as low quality as they lacked a protocol or
did not consider risk of bias, so findings need to be interpreted
with caution.
Future meta-reviews would benefit from looser inclusion criteria
to capture other types of reviews containing evidence on
emerging innovations such as wearables, smartphone apps,
robotics and artificial intelligence. Since the Covid-19 pandemic
has greatly accelerated the use of novel digital health innovations
and presents particular risks and barriers for the elderly and
vulnerable, a large increase in published studies on new forms of
service delivery may be expected in the coming year, which will
call for new reviews of relevant evidence in palliative care.
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METHODS
Design
We undertook a systematic review of published systematic reviews,
or a ‘meta-review’, to provide a single synthesis of relevant
evidence on the use and effectiveness of DHIs for terminally ill
patients and their families. Meta-reviews are useful in areas where
numerous systematic reviews exist but vary in timeliness, scope and
quality, making them difficult to interpret and use for evidence-
based decision-making. Undertaking a meta-review typically
involves applying a structured search strategy, filtering and critically
appraising relevant systematic reviews, descriptive summarisation
of the evidence base and thematic synthesis of the reviews’
findings and conclusions. Additional rigour can be provided by also
critically appraising the primary studies contained within each
review, although this is less common66. Our review considered
systematic reviews as the main units of analysis. We nonetheless
checked details of their included articles to identify the total
number of unique publications, then classified these based on the
type and purpose of the DHI reported, and the level of evidence
suggested by their study designs.
Protocol
A review protocol was developed in advance of conducting this
meta-review and shared with the Research Ethics Subgroup in the
Centre of Population Health Sciences at the University of
Edinburgh. As this review started out as a postgraduate student
project, it was not pre-registered on PROSPERO.
Search strategy
The search strategy included the following databases: MEDLINE,
MEDLINE In-Process & Other Non-Indexed Citations; EMBASE,
PsychINFO, CINAHL, Cochrane Database for Systematic Reviews;
Cochrane Database of Abstracts of Reviews of Effects; WHO Global
Library (regional indexes only) and Web of Science. The Grey
Literature Report (www.greylit.org) was also searched using
keywords tailored for this database. The search terms included
MeSH headings and keywords related to digital health, palliative
care and technology. All search strategies can be found in the
supplementary information file (see Supplementary Note 1).
Searches were limited to articles published after 2006 to ensure
relevance, given rapidly evolving technologies. There were no
restrictions placed on language. The initial searches were
conducted in June 2018; and subsequently extended, to capture
additional studies published up to January 2020.
Inclusion criteria
The search strategy targeted systematic reviews explicitly focused on
DHIs in palliative care. Drawing on previous definitions of a
systematic review, we included reviews with a clearly formulated
question that uses systematic and explicit methods to identify, select
and critically appraise relevant research67. We excluded rapid
reviews and non-systematic scoping reviews, as well as reviews
where search strategies were limited to one database, formal
evidence appraisal was not undertaken, or data from individual
studies were not summarized. Systematic reviews on broader topics
were also included, provided these separately reported or synthe-
sized studies of DHIs in palliative care. Using the PICO process68, we
defined our target population (P) as children and adults who would
benefit from palliative care, caregivers (informal and formal) and
healthcare professionals delivering palliative care via DHIs or using
DHIs to support palliative care decision-making. For the purposes of
this review DHIs (I), were defined as approaches in which digital ICTs
are used to deliver, facilitate or augment palliative care services,
including psychological therapies, social support interventions,
education, information, anticipatory care planning, remote care
support, self-medication/management support, CDS etc. Examples of
relevant ICTs include telephone, smartphone apps, mobile phones/
SMS, videoconferencing, voice over IP, instant messaging, email,
internet resources, tablets, wearables, electronic patient records.
Both synchronous (e.g. videoconferencing) and asynchronous (e.g.
email) approaches were included. Our comparator of interest (C) was
no DHIs or usual care. No limitations were placed on outcomes (O),
as we were interested in identifying the broad range of outcomes
potentially influenced by palliative care DHIs.
Data extraction
The co-first authors (A.M.F. and H.O’D.) undertook the database
searches and initial screening of titles and abstracts. Where
uncertainty existed in relation to potential eligibility, titles and
abstracts were independently screened by a third author and
ambiguities or disagreements resolved through discussion with
the wider team. H.O’D. and A.M.F. independently assessed papers
identified for full-text review, with CP arbitrating where it was
unclear whether a review paper should be included. Disagree-
ments and uncertainties were resolved during full team discus-
sions and the authors came to a 100% agreement.
Three co-authors extracted the following information from each
of the included systematic reviews: authors, date of publication,
country, review aims, search strategy, number of studies included,
total number of participants, definition of palliative care, details of
participants, functions and medium of DHIs included, reported
outcomes, quality assessment methods and conclusions. They
then extracted the types of digital health technologies and the
intended purposes of the technologies from the individual studies
from the included reviews and sought advice from to a fourth co-
author in cases of uncertainty.
We applied the PDQ Levels of Evidence framework described by
the National Cancer Institute36 to appraise Supportive and
Palliative Care research, to categorise publications within the
systematic reviews into one of four levels. Level 1 represented
study designs typically considered to offer the strongest evidence
and Level 4 the weakest.
Quality appraisal
The Assessment of Multiple Systematic Reviews (AMSTAR 2)
checklist was used to critically appraise the included reviews69.
This process was undertaken by three co-authors (A.M.F., J.L. and
T.G.-W.). In advance of conducting the appraisal, each read the
AMSTAR 2 guidance, and met to discuss the interpretation of tool
for the present study. Two co-authors independently judged each
review based on each of the 16 items identified in the AMSTAR 2.
Three co-authors then met to compare item judgements for each
of the 21 reviews. Final judgements were agreed through further
discussion and consensus. Drawing on item judgements, an
overall quality rating of the review was made based on the
inclusion of AMSTAR 2 critical domains in each review. These
judgements were based on the guidance described by Shea
et al.69, which emphasizes an overall judgement of confidence
based on critical and non-critical elements of the reviews, as
opposed to calculating overall review scores. Given the hetero-
geneity of study designs in the included reviews, we viewed four
domains as critical: protocol registered prior to commencement of
the study (AMSTAR item 2), adequacy of the literature search
(AMSTAR item 4), consideration of risk of bias when interpreting
results (Amstar item 13) and discussion of heterogeneity observed
in the results where relevant (Amstar Item 14). We rated quality
based on overall confidence in the results of the review as follows:
high: where all critical domains and no more than one non-critical
weakness was evident, moderate: where all critical domains with
few non-critical weaknesses were identified, low: where between
one and two critical domains were not examined and very low:
where three or more critical domains were not examined and
numerous non-critical weaknesses were identified.
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Data synthesis
Based on our preliminary scoping work, we expected substantial
heterogeneity amongst included reviews, several of which would
themselves include a heterogeneous group of study designs. We
therefore planned to categorise the key outcomes identified
across all reviews during data extraction and undertake a narrative
synthesis of the main findings related to these outcomes. All
reviews were imported into NVivo 12, which we used to support
the data analysis and synthesis process.
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